Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Brock P. Whittenberger

Hematology Oncology
801 N 29th St, 
Billings, MT 

Experienced in WT1-Related Wilms Tumor Syndromes
801 N 29th St, 
Billings, MT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Brock Whittenberger is a Hematologist Oncology provider in Billings, Montana. Dr. Whittenberger is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Multiple Myeloma, Richter Syndrome, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

His clinical research consists of co-authoring 1 peer reviewed article and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in MT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

801 N 29th St, Billings, MT 59101
Call: 406-238-2500

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
monarcHER: A Phase 2, Randomized, Multicenter, 3-Arm, Open-Label Study to Compare the Efficacy of Abemaciclib Plus Trastuzumab With or Without Fulvestrant to Standard-of-Care Chemotherapy of Physician's Choice Plus Trastuzumab in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
monarcHER: A Phase 2, Randomized, Multicenter, 3-Arm, Open-Label Study to Compare the Efficacy of Abemaciclib Plus Trastuzumab With or Without Fulvestrant to Standard-of-Care Chemotherapy of Physician's Choice Plus Trastuzumab in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Completed
Publish Date: November 26, 2024
Intervention Type: Drug
Study Drugs: Abemaciclib, Trastuzumab, Fulvestrant, Standard of Care Single Agent Chemotherapy
Study Phase: Phase 2
A Phase 2 Study of Brentuximab Vedotin in Combination With Standard of Care Treatment (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [RCHOP]) or RCHP (Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone) as Front-line Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
A Phase 2 Study of Brentuximab Vedotin in Combination With Standard of Care Treatment (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [RCHOP]) or RCHP (Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone) as Front-line Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Terminated
Publish Date: June 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

1 Total Publications

High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis.
High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis.
Journal: Physical biology
Published: February 07, 2012
Similar Doctors
Michael T. Kidd
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael T. Kidd
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael T. Kidd
Hematology Oncology | Hematology | Oncology

Billings Clinic

801 N 29th St, 
Billings, MT 
 (0.1 miles away)
406-238-2500
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Kidd is a Hematologist Oncology specialist and a Hematologist in Billings, Montana. Dr. Kidd has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Neuroendocrine Tumor, Breast Cancer in Men, Paget Disease of the Breast, and Chronic Lymphocytic Leukemia (CLL).

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Kristina M. Hool
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Kristina M. Hool
Hematology Oncology | Hematology | Oncology

Scl Health Montana

1315 Golden Valley Cir, 
Billings, MT 
 (4.0 miles away)
406-238-6290
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kristina Hool is a Hematologist Oncology specialist and a Hematologist in Billings, Montana. Dr. Hool is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Astrocytoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Hool is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Patrick W. Cobb
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Patrick W. Cobb
Hematology Oncology | Hematology | Oncology
1315 Golden Valley Cir, 
Billings, MT 
 (4.0 miles away)
406-238-6290
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Patrick Cobb is a Hematologist Oncology specialist and a Hematologist in Billings, Montana. Dr. Cobb is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Cobb is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Whittenberger's expertise for a condition
ConditionClose
      • Advanced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Whittenberger is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Angiosarcoma
        Dr. Whittenberger is
        Advanced
        . Learn about Angiosarcoma.
        See more Angiosarcoma experts
      • Autoimmune Hemolytic Anemia
        Dr. Whittenberger is
        Advanced
        . Learn about Autoimmune Hemolytic Anemia.
        See more Autoimmune Hemolytic Anemia experts
      • Breast Cancer
        Dr. Whittenberger is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      • Childhood Acute Myeloid Leukemia
        Dr. Whittenberger is
        Advanced
        . Learn about Childhood Acute Myeloid Leukemia.
        See more Childhood Acute Myeloid Leukemia experts
      • Chronic B-Cell Leukemia (CBCL)
        Dr. Whittenberger is
        Advanced
        . Learn about Chronic B-Cell Leukemia (CBCL).
        See more Chronic B-Cell Leukemia (CBCL) experts
      View All 33 Advanced Conditions
      • Experienced
      • Acquired Agranulocytosis
        Dr. Whittenberger is
        Experienced
        . Learn about Acquired Agranulocytosis.
        See more Acquired Agranulocytosis experts
      • Acute Lymphoblastic Leukemia (ALL)
        Dr. Whittenberger is
        Experienced
        . Learn about Acute Lymphoblastic Leukemia (ALL).
        See more Acute Lymphoblastic Leukemia (ALL) experts
      • Acute Monoblastic Leukemia (AmoL)
        Dr. Whittenberger is
        Experienced
        . Learn about Acute Monoblastic Leukemia (AmoL).
        See more Acute Monoblastic Leukemia (AmoL) experts
      • Acute Mountain Sickness
        Dr. Whittenberger is
        Experienced
        . Learn about Acute Mountain Sickness.
        See more Acute Mountain Sickness experts
      • Acute Myeloblastic Leukemia with Maturation
        Dr. Whittenberger is
        Experienced
        . Learn about Acute Myeloblastic Leukemia with Maturation.
        See more Acute Myeloblastic Leukemia with Maturation experts
      • Acute Myeloblastic Leukemia without Maturation
        Dr. Whittenberger is
        Experienced
        . Learn about Acute Myeloblastic Leukemia without Maturation.
        See more Acute Myeloblastic Leukemia without Maturation experts
      View All 112 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved